Technology Opportunities

THE NEED The current treatment of multiple myeloma (MM) included standard chemotherapy and small molecules such as the proteasome inhibitor and the immunomodulatory drugs. Although these drugs have improved the response and survival of MM patients, MM is still an incurable disease. Drug ...

BackgroundChemotherapy treatment is generally accompanied by adverse effects, which can be significantly reduced using site specific, targeted delivery systems, such as antibody-coated LNPs (immuno-LNPs). However due to inter-and intra-tumor heterogeneity targeting with a single targeting ...

A complex comprising RNA and a positively charged modified polysaccharide selected from starch, amylose, amylopectin, galactan, chitosan, or dextrin, pharmaceutical composition comprising it, and its use in RNA transfection are provided. Methods for RNA transfection, gene therapy and treatment ...

The laboratory of Precision Nanomedicine at TAU have capabilities for preparation and characterization of nanocarriers made from natural biopolymers such as lipids (liposomes, micelles) , sugars and proteins. Lab Description• State-of-the-art preparation and process development of lipid ...